Medartis Inc. Announces Strategic Alliance with Field Orthopaedics

Medartis, a specialized orthopaedic company for head and extremity surgery, announced that it has entered into an exclusive global distribution partnership with the Australian-based Field Orthopaedics.

Medartis, a specialized orthopaedic company for head and extremity surgery, announced that it has entered into an exclusive global distribution partnership with the Australian-based Field Orthopaedics. This strategic partnership will include the addition of the NX Nail system to Medartis’ comprehensive hand portfolio.

This strategic alliance will enable Medartis to further leverage the NX Nail’s intraosseous, minimally invasive treatment options for fractures of the metacarpal and phalanx. This agreement will provide additional growth opportunities in the US extremities market and potentially in additional markets.

The NX Nail system is a complementary product to the Medartis plating systems and CCS screw portfolio. The role of this implant is to rigidly fix bone fragments in space while crossing the fracture to act as a strut. The NX Nail acts as a physiological splint, designed to withstand normal loads and to facilitate rapid return to normal activity. The company plans to begin distributing the products in Q4 2022.

“We’re excited about this new partnership with Field Orthopaedics and see the NX Nail system as value added for our clients,” Ryan Schlotterback, Chief Technology Officer (US) for Medartis, commented. “The NX Nail system addresses the growing need of surgeons for an efficient, less invasive treatment that enables rapid recovery of patients after a finger fracture. NX Nail is the most comprehensive hand nailing system on the market and it perfectly complements our APTUS hand plate and screw portfolio.”

Patryk Kania, CEO Field Orthopaedics stated, “We are excited about this collaboration.  Medartis is a top player in musculoskeletal extremity healthcare and specifically in orthopaedic hand surgery. By combining its global reach and commercial expertise with Field Orthopaedics’ innovative solutions for hand extremity trauma, we can rapidly extend our sales and distribution footprint, and ultimately reach more patients in more countries. It’s fantastic that two organizations driven by excellence and innovation can partner to provide the most comprehensive hand surgery offerings for surgeons and their patients.”

Medartis will be exhibiting at the annual American Society for Surgery of the Hand in Boston. Come to booth #906 to learn more about the comprehensive portfolio of Medartis products as well as the NX Nail system.

 

About Medartis

Founded in 1997 and headquartered in Basel, Switzerland, Medartis is one of the world’s leading manufacturers and providers of medical devices for surgical fixation of bone fractures for upper and lower extremities as well as for the craniomaxillofacial region. Medartis employs more than 700 individuals across its 14 locations, with products offered in over 50 countries globally. Medartis is committed to providing surgeons and operating theatre personnel with the most innovative titanium implants and instruments as well as best-in-class service. For more information on Medartis worldwide activities, please visit www.medartis.com.

About Field Orthopaedics

Formed in 2015 and headquartered in Brisbane, Australia, Field Orthopaedics is an orthopaedic start-up dedicated to innovating and delivering best in class medical implants and solutions to advance primarily hand surgery and benefit society. Field Orthopaedics is committed to bring together ideas & innovation to build what hand surgeons need to get patients to activity faster. For more information on Field Orthopaedics, please visit www.fieldorthopaedics.com.

 

Media inquiries:
Medartis US Media Relations
Media contact: corpcomm.us@medartis.com

×

What are you looking for?